Abacavir
Showing 1 - 25 of 297
Abacavir and Lamivudine Anabolites
Completed
- HIV-1-infection
- Blood collection
- +3 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 5, 2023
HIV-1-infection Trial in Montréal (abacavir, dolutegravir and lamivudine dispersible tablets, Triumeq Dispersible Tablets 5 mg
Completed
- HIV-1-infection
- abacavir, dolutegravir and lamivudine dispersible tablets
- Triumeq Dispersible Tablets 5 mg GSK1349572 [Dolutegravir]/ 60 mg Abacavir/ 30 mg Lamivudine
-
Montréal, Quebec, CanadaAltasciences
Mar 10, 2022
Aicardi-Goutières Syndrome Trial in Edinburgh (Abacavir (ABC), Lamivudine (3TC), Abacavir (ABC)+Lamivudine (3TC)+Zidovudine
Recruiting
- Aicardi-Goutières Syndrome
- Abacavir (ABC)
- +2 more
-
Edinburgh, United KingdomYanick Crow
Aug 26, 2022
HIV Trial (Abacavir sulfate, Mycophenolate mofetil)
Withdrawn
- HIV Infections
- Abacavir sulfate
- Mycophenolate mofetil
- (no location specified)
Oct 28, 2021
HIV, Acute HIV Infection Trial in Chapel Hill, Durham (Dolutegravir 50 mg, Lamivudine 300 mg, Abacavir 600 mg)
Completed
- HIV
- Acute HIV Infection
- Dolutegravir 50 mg
- +2 more
-
Chapel Hill, North Carolina
- +1 more
Oct 22, 2021
Hiv, HIV, HIV Cardiomyopathy Trial in Denmark (Dolutegravir / Lamivudine Oral Tablet)
Recruiting
- Hiv
- +5 more
- Dolutegravir / Lamivudine Oral Tablet
-
Aalborg, Denmark
- +4 more
May 26, 2021
HIV Trial in United States (Abacavir sulfate)
Completed
- HIV Infections
- Abacavir sulfate
-
Birmingham, Alabama
- +23 more
Oct 28, 2021
HIV Trial in Puerto Rico, United States (Abacavir sulfate, lamivudine, and zidovudine, Lamivudine/zidovudine,
Completed
- HIV Infections
- Abacavir sulfate, lamivudine, and zidovudine
- +2 more
-
Los Angeles, California
- +7 more
Oct 28, 2021
Platelet Function on Abacavir and Tenofovir
Completed
- Cardiovascular Diseases
- +2 more
- Platelet aggregation
-
Los Angeles, CaliforniaClinical AIDS Research and Education Center
Nov 17, 2020
HIV-1 Infection Trial in Worldwide (Lopinavir/ritonavir, Raltegravir, Emtricitabine/tenofovir disoproxil fumarate)
Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK744, GSK744 LA, TMC278 LA)
Active, not recruiting
- Infection, Human Immunodeficiency Virus
- HIV Infections
- GSK744
- +4 more
-
Birmingham, Alabama
- +49 more
Dec 26, 2022
HIV Trial in United States (Abacavir sulfate, Emtricitabine, Lamivudine)
Completed
- HIV Infections
- Abacavir sulfate
- +6 more
-
Chicago, Illinois
- +3 more
Oct 28, 2021
HIV Trial in Puerto Rico, United States (Indinavir sulfate, Abacavir sulfate, Efavirenz)
Completed
- HIV Infections
- Indinavir sulfate
- +2 more
-
Los Angeles, California
- +55 more
Oct 28, 2021
HIV Trial in United States (Abacavir sulfate, Lamivudine, Stavudine)
Completed
- HIV Infections
- Abacavir sulfate
- +4 more
-
Los Angeles, California
- +6 more
Oct 27, 2021
Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir/abacavir/lamivudine FDC, Atazanavir, Ritonavir)
Active, not recruiting
- Infection, Human Immunodeficiency Virus
- HIV Infections
- Dolutegravir/abacavir/lamivudine FDC
- +3 more
-
Phoenix, Arizona
- +88 more
Feb 8, 2022
HIV Trial in United States (Abacavir sulfate, Nelfinavir mesylate, Nevirapine)
Completed
- HIV Infections
- Abacavir sulfate
- +5 more
-
Gainesville, Florida
- +11 more
Oct 27, 2021
Renal Insufficiency,Chronic, Hiv, Therapeutic Agent Toxicity Trial in Arnhem, Amsterdam, Rotterdam (tenofovir alafenamide,
Unknown status
- Renal Insufficiency,Chronic
- +2 more
- tenofovir alafenamide
- abacavir
-
Arnhem, Gelderland, Netherlands
- +4 more
Jan 27, 2020